Today, Movano Inc. (NASDAQ:MOVE) announced the pricing of its initial public offering of 8,500,000 shares of its common stock at a public offering price of $5.00 per share.

Manufactured on GF’s 22FDX platform, Movano’s radio frequency-enabled solution will help individuals to manage their glucose levels anywhere, anytime

After announcing $10M in bridge funding in July, the company raised an additional $2.5M to progress the development of its wearable non-invasive continuous glucose monitor

Company’s needle-free wearable technology will provide painless, real-time glucose readings at the glance of a wrist